AQR Capital Management, LLC and its parent AQR Capital Management Holdings, LLC reported beneficial ownership of 2,266,489 shares of Haemonetics Corp common stock, representing 4.99% of the class as of 06/30/2026.
AQR Capital Management, LLC and its parent AQR Capital Management Holdings, LLC reported beneficial ownership of 2,266,489 shares of Haemonetics Corp common stock, representing 4.99% of the class as of 06/30/2026. Both entities report shared voting power over 2,149,735 shares and shared dispositive power over 2,266,489 shares, with no sole voting or dispositive power. AQR Capital Management, LLC is a wholly owned subsidiary of AQR Capital Management Holdings, LLC.
Key Figures
Shares beneficially owned:2,266,489 sharesPercent of class:4.99%Shared voting power:2,149,735 shares+3 more
6 metrics
Shares beneficially owned2,266,489 sharesHaemonetics Corp common stock beneficially owned by AQR entities
Percent of class4.99%Percentage of Haemonetics Corp common stock class held by AQR entities
Shared voting power2,149,735 sharesShares of Haemonetics Corp over which AQR has shared voting power
Shared dispositive power2,266,489 sharesShares of Haemonetics Corp over which AQR has shared dispositive power
Event date06/30/2026Date associated with the reported ownership position
Signature date08/12/2026Date the Schedule 13G/A was signed by the authorized signatory
Key Terms
beneficially owned, shared voting power, shared dispositive power, percent of class, +1 more
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
shared voting powerfinancial
"6 | Shared Voting Power 2,149,735.00"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
Percent of class is the portion of a specific category of securities—such as a company’s common shares, preferred shares, or a bond series—that takes part in or approves a corporate action (vote, consent, tender, etc.). Investors watch this number because it reveals how much support or opposition exists within that particular shareholder group; like counting how many members of a club back a proposal, it can determine whether a plan passes or how influence is distributed.
parent holding companyfinancial
"If a parent holding company has filed this schedule, pursuant to (ii)(G)"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What percentage of Haemonetics Corp (HAE) shares does AQR currently report owning?
AQR Capital Management entities report beneficial ownership of 4.99% of Haemonetics Corp common stock. This corresponds to 2,266,489 shares of common stock, according to the Schedule 13G/A as of June 30, 2026.
How many Haemonetics Corp (HAE) shares does AQR report as beneficially owned?
AQR Capital Management, LLC and AQR Capital Management Holdings, LLC report beneficial ownership of 2,266,489 shares of Haemonetics Corp common stock. This position represents 4.99% of the outstanding common stock class.
What voting power does AQR have over Haemonetics Corp (HAE) shares?
AQR reports shared voting power over 2,149,735 shares of Haemonetics Corp and no sole voting power. Both AQR Capital Management, LLC and its parent report identical shared voting power figures.
What dispositive power does AQR hold over its Haemonetics Corp (HAE) position?
AQR reports shared dispositive power over 2,266,489 shares of Haemonetics Corp common stock and no sole dispositive power. The same amounts are reported by both AQR Capital Management, LLC and AQR Capital Management Holdings, LLC.
Who filed the Haemonetics Corp (HAE) Schedule 13G/A and how are they related?
The filing was made by AQR Capital Management, LLC and AQR Capital Management Holdings, LLC. AQR Capital Management, LLC is described as a wholly owned subsidiary of AQR Capital Management Holdings, LLC, and the filing is made on behalf of both entities.
Does the AQR filing indicate ownership of 5 percent or less of Haemonetics Corp (HAE)?
Yes. The Schedule 13G/A states a percent of class of 4.99% and includes an indication of ownership of 5 percent or less of Haemonetics Corp’s common stock class.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. 1)
HAEMONETICS CORP
(Name of Issuer)
Common stock, $0.01 par value per share
(Title of Class of Securities)
405024100
(CUSIP Number)
06/30/2026
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)
schemaVersion:
SCHEDULE 13G
CUSIP Number(s):
405024100
1
Names of Reporting Persons
AQR Capital Management, LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
UNITED STATES
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
2,149,735.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
2,266,489.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
2,266,489.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
4.99 %
12
Type of Reporting Person (See Instructions)
IA
SCHEDULE 13G
CUSIP Number(s):
405024100
1
Names of Reporting Persons
AQR Capital Management Holdings, LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
UNITED STATES
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
2,149,735.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
2,266,489.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
2,266,489.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
4.99 %
12
Type of Reporting Person (See Instructions)
HC
SCHEDULE 13G
Item 1.
(a)
Name of issuer:
HAEMONETICS CORP
(b)
Address of issuer's principal executive offices:
125 SUMMER STREET, BOSTON, MASSACHUSETTS
02110
Item 2.
(a)
Name of person filing:
AQR Capital Management, LLC
AQR Capital Management Holdings, LLC
(b)
Address or principal business office or, if none, residence:
ONE GREENWICH PLAZA
SUITE 130
Greenwich, Connecticut
06830
(c)
Citizenship:
AQR Capital Management, LLC - UNITED STATES
AQR Capital Management Holdings, LLC - UNITED STATES
(d)
Title of class of securities:
Common stock, $0.01 par value per share
(e)
CUSIP No.:
405024100
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
(k)
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.
Ownership
(a)
Amount beneficially owned:
2,266,489
(b)
Percent of class:
4.99 %
(c)
Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
AQR Capital Management, LLC - 0
AQR Capital Management Holdings, LLC - 0
(ii) Shared power to vote or to direct the vote:
AQR Capital Management, LLC - 2,149,735
AQR Capital Management Holdings, LLC - 2,149,735
(iii) Sole power to dispose or to direct the disposition of:
AQR Capital Management, LLC - 0
AQR Capital Management Holdings, LLC - 0
(iv) Shared power to dispose or to direct the disposition of:
AQR Capital Management, LLC - 2,266,489
AQR Capital Management Holdings, LLC - 2,266,489
Item 5.
Ownership of 5 Percent or Less of a Class.
Ownership of 5 percent or less of a class
Item 6.
Ownership of more than 5 Percent on Behalf of Another Person.
Not Applicable
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary.
See Item 2(a) above.
Item 8.
Identification and Classification of Members of the Group.
Not Applicable
Item 9.
Notice of Dissolution of Group.
Not Applicable
Item 10.
Certifications:
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
AQR Capital Management, LLC
Signature:
Henry Parkin
Name/Title:
Authorized Signatory
Date:
08/12/2026
AQR Capital Management Holdings, LLC
Signature:
Henry Parkin
Name/Title:
Authorized Signatory
Date:
08/12/2026
Exhibit Information
AQR Capital Management Holdings, LLC and AQR Capital Management, LLC hereby agree that this Schedule 13G is filed on behalf of each of the parties. AQR Capital Management, LLC is a wholly owned subsidiary of AQR Capital Management Holdings, LLC.
